Tropical Tick‑Borne Fever Protocols

Structured approach to suspected canine tick fever in Indian OPD practice.

Clinical Guide

Step 1 • Case Recognition

When to Suspect Tick‑Borne Fever

In endemic Indian regions, tick‑borne disease should be high on the differential list in many febrile, lethargic dogs even before classic bleeding signs appear.

  • History: outdoor or semi‑outdoor lifestyle, recent tick removal, irregular acaricide use, or exposure to stray dogs.
  • Presenting signs: fever, lethargy, inappetence, weight loss, pale or icteric mucosa, lymphadenopathy, splenomegaly, shifting‑leg lameness, +/- vomiting or diarrhoea.
  • Red flags for severe disease: petechiae, ecchymoses, epistaxis, melena, haemoglobinuria, respiratory distress, seizures, or ataxia.
Clinical pearl: In endemic areas, fever plus thrombocytopenia with or without anaemia is highly suspicious for tick‑borne disease even if the first smear is negative.

Step 2 • Likely Pathogens

Core Differentials in Indian Dogs

Co‑infections are not rare; thrombocytopenia or anaemia may reflect more than one organism.

Pathogen Typical picture Key clues
Ehrlichia canis Acute or chronic illness, weight loss, fever, bleeding tendencies, ocular changes. Marked thrombocytopenia, +/- pancytopenia, hyperglobulinaemia, large granular lymphocytes.
Babesia spp. Acute haemolytic crisis with pale or icteric mucosa, dark urine, tachycardia, rapid deterioration. Regenerative anaemia, haemoglobinuria, piroplasms on smear (ear/venous capillary sample often helpful).
Anaplasma spp. Mild to moderate fever, lethargy, sometimes lameness or joint pain. Thrombocytopenia, morulae in platelets or neutrophils, frequent co‑infection with Ehrlichia.

Step 3 • Minimum Database

Practical Diagnostics for OPD

Start with what is realistically available on‑site, then layer on advanced tests as the case and owner allow.

  • CBC with platelet count: assess anaemia pattern, leukogram, thrombocytopenia; chronic ehrlichiosis often shows pancytopenia.
  • Peripheral smear: examine buffy coat and capillary/ear prick smears for Ehrlichia morulae and Babesia piroplasms; a negative smear does not exclude infection.
  • Basic biochemistry: liver and kidney parameters, total protein/albumin, glucose to guide fluid plans and drug choices.
  • Serology or PCR (where available): helpful for confirming exposure or active infection and identifying co‑infections.
Admit or refer urgently if: PCV is critically low with collapse, there is severe dyspnoea, uncontrolled bleeding, seizures, or suspected ARDS — these dogs may need oxygen, transfusion, and intensive monitoring.

Step 4 • Decision Flow

Treat Now vs Wait for Results

In high‑burden regions, delaying empirical therapy in unstable dogs while waiting for advanced tests can be risky.

  • High suspicion + unstable dog (shock, severe anaemia, active bleeding): stabilise, start coverage for tick‑borne disease, consider transfusion thresholds, and send confirmatory tests when feasible.
  • High suspicion + limited diagnostics: begin doxycycline‑based therapy and supportive care, then refine the diagnosis with smear / serology / PCR as they become available.
  • Low suspicion or competing diagnosis stronger: manage the primary problem but re‑evaluate CBC, platelets, and smear if fever or cytopenias persist.

Step 5 • Therapy Snapshots

Treatment Outlines (Reference Only)

The following reflect approaches commonly described in veterinary literature; adapt to the individual patient and current national recommendations.

Condition Antimicrobial outline Supportive notes
Canine monocytic ehrlichiosis Doxycycline around 10 mg/kg once daily (or 5 mg/kg twice daily) for approximately 28 days is widely cited. Monitor appetite and GI tolerance; recheck platelets and CBC during and after therapy. Address concurrent anaemia, hypoalbuminaemia, and secondary infections.
Babesiosis (uncomplicated) Imidocarb dipropionate in the region of 6–6.6 mg/kg IM/SC, often repeated after about 14 days, is frequently reported. Consider anticholinergic premedication; provide IV fluid and red cell support as indicated; monitor for haemoglobinuria and renal compromise.
Suspected co‑infection (Ehrlichia / Anaplasma + Babesia) Combine an appropriate doxycycline course with anti‑babesial treatment, guided by diagnostics and stability. These dogs may deteriorate quickly; monitor PCV, platelets, and vital signs closely, and plan fluid and transfusion support proactively.

Step 6 • Follow‑Up & Prevention

Monitoring Recovery and Owner Messaging

Structured follow‑up helps detect relapses early and reinforces long‑term tick control.

  • Recheck timelines: many clinicians re‑evaluate at 7–14 days and again near the end of therapy, repeating CBC (± smear) to confirm platelet and red cell recovery.
  • Chronic ehrlichiosis: some dogs can show persistent hyperglobulinaemia, weight loss, or cytopenias despite initial therapy and may need extended monitoring and further investigation.
  • Prevention: emphasise year‑round tick control in endemic areas and realistic compliance plans with the owner.